Le Lézard
Classified in: Science and technology
Subjects: Conference, Event, Trade Show

SolarWinds to Showcase Enhanced Orion Platform at GITEX Technology Week 2019


SolarWinds (NYSE:SWI), a leading provider of powerful and affordable IT management software, today announced its participation at GITEX Technology Week, October 6 ? 10, 2019, in Dubai, United Arab Emirates. The company, who holds the May 2019 Gartner® Peer Insightstm Customers' Choice distinction for Network Performance Monitoring and Diagnostics^ will exhibit the latest updates to its SolarWinds® Orion® Platform.

TrustRadius®, one of the most trusted customer review platform for B2B technology, recently named

SolarWinds Server & Application Monitor (SAM), Database Performance Analyzer (DPA), Virtualization Manager (VMAN), and Network Performance Monitor (NPM) as 2019 Top Rated Products.

"For the past 20 years, SolarWinds has dedicated itself to equipping technology professionals with powerful solutions they need to effectively monitor, manage, and secure their evolving IT environments," said Ludovic Neveu, group vice president, sales, SolarWinds, Europe, Middle East, and Africa (EMEA). "The recent accolades from Gartner Peer Insights Customers' Choice and TrustRadius demonstrate our ongoing commitment to incorporating customer feedback into our product development. We're thrilled to see our Middle Eastern customers champion our solutions."

Visit SolarWinds at Booth H7-D40

New this year, two value-added distribution (VAD) partners will join the SolarWinds technical team of experts: Clever Distribution and Spire Solutions.

"Last year's show was a success for us and we're looking forward to strengthening the relationships we started building in 2018," continued Neveu. "Clever and Spire are key partners for us in the region, and we believe they can assist us in increasing our footprint across this market, supporting us in reaching a broader audience of potential resellers who can promote and deliver SolarWinds products to their customers."

SolarWinds Head Geektm Patrick Hubbard, along with VAD partners, will demonstrate the latest updates and enhancements to the SolarWinds Orion Platform, including:

SolarWinds Orion Platform

The Orion Platform is a modular and scalable architecture built to deliver powerful network, infrastructure, and application monitoring and management capabilities across on-premises, hosted, and public cloud environments. The common framework combines a web-based dashboard, centralized user management, unified alerting and reporting, and consolidated metrics?enhancing collaboration between teams. In addition to the PerfStacktm dashboard improvements and centralized upgrades, the latest release of the Orion Platform also adds SAML authentication support, enabling Single Sign On (SSO) to the Orion Web Console.

For more information on SolarWinds IT management products, including downloadable, free 30-day evaluations, visit the SolarWinds website or call +353 21 500 2900.

Additional Resources

Connect with SolarWinds

^Gartner Peer Insights Customers' Choice constitute the subjective opinions of individual end-user reviews, ratings, and data applied against a documented methodology; they neither represent the views of, nor constitute an endorsement by, Gartner or its affiliates.

#SWIevents
#SWIproducts

About SolarWinds

SolarWinds (NYSE:SWI) is a leading provider of powerful and affordable IT infrastructure management software. Our products give organizations worldwide, regardless of type, size or IT infrastructure complexity, the power to monitor and manage the performance of their IT environments, whether on-premises, in the cloud, or in hybrid models. We continuously engage with all types of technology professionals?IT operations professionals, DevOps professionals, and managed service providers (MSPs)?to understand the challenges they face maintaining high-performing and highly available IT infrastructures. The insights we gain from engaging with them, in places like our THWACK online community, allow us to build products that solve well-understood IT management challenges in ways that technology professionals want them solved. This focus on the user and commitment to excellence in end-to-end hybrid IT performance management has established SolarWinds as a worldwide leader in network management software and MSP solutions. Learn more today at www.solarwinds.com.

The SolarWinds, SolarWinds & Design, Orion, and THWACK trademarks are the exclusive property of SolarWinds Worldwide, LLC or its affiliates, are registered with the U.S. Patent and Trademark Office, and may be registered or pending registration in other countries. All other SolarWinds trademarks, service marks, and logos may be common law marks or are registered or pending registration. All other trademarks mentioned herein are used for identification purposes only and are trademarks of (and may be registered trademarks of) their respective companies.

© 2019 SolarWinds Worldwide, LLC. All rights reserved.


These press releases may also interest you

at 08:05
Axcella Health Inc. , a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism and support health, today announced mechanistic data for AXA4010 that are being presented...

at 08:00
Genius Central, founded in October 1999, is celebrating 20 years in business providing essential components of the supply chain to the natural and specialty grocery industry. Processing over $2 billion in orders annually, the company's mission to...

at 08:00
Cellular Biomedicine Group Inc. ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies, announced early data from its ongoing investigator initiated trial ("IIT") at...

at 07:55
AstraZeneca today presented results from the interim analysis of the Phase III ELEVATE TN trial, showing that CALQUENCE® (acalabrutinib) combined with obinutuzumab or as monotherapy significantly improved progression-free survival (PFS) compared to...

at 07:33
AbbVie , a research-based global biopharmaceutical company, today announced results from an extended follow-up analysis of the Phase 3 E1912 clinical study ? designed and conducted by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and sponsored by...

at 07:30
AbbVie , a research-based global biopharmaceutical company, today announced new data from the Phase 2 CAPTIVATE (PCYC-1142) clinical trial,1 evaluating IMBRUVICA® (ibrutinib) in combination with VENCLEXTA®/VENCLYXTO® (venetoclax) in previously...



News published on 7 october 2019 at 03:05 and distributed by: